{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:36:05Z","timestamp":1764020165595},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.addbeh.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T18:01:42Z","timestamp":1499882502000},"page":"122-129","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Measures and predictors of varenicline adherence in the treatment of nicotine dependence"],"prefix":"10.1016","volume":"75","author":[{"given":"Annie R.","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Paul","family":"Wileyto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Larry W.","family":"Hawk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Cinciripini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony P.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal L.","family":"Benowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole L.","family":"Nollen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caryn","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel F.","family":"Tyndale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Schnoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.addbeh.2017.07.006_bb0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1037\/0893-164X.12.2.101","article-title":"Reliability and validity of a smoking timeline follow-back interview","volume":"12","author":"Brown","year":"1998","journal-title":"Psychology of Addictive Behaviors"},{"issue":"9","key":"10.1016\/j.addbeh.2017.07.006_bb0010","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ntr\/ntr333","article-title":"Adherence to varenicline among African American smokers: An exploratory analysis comparing plasma concentration, pill count, and self-report","volume":"14","author":"Buchanan","year":"2012","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1016\/j.addbeh.2017.07.006_bb0015","first-page":"Cd009329","article-title":"Pharmacological interventions for smoking cessation: An overview and network meta-analysis","volume":"5","author":"Cahill","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1016\/j.addbeh.2017.07.006_bb0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ntr\/ntr003","article-title":"Adherence to varenicline in the COMPASS smoking cessation intervention trial","volume":"13","author":"Catz","year":"2011","journal-title":"Nicotine & Tobacco Research"},{"issue":"9","key":"10.1016\/j.addbeh.2017.07.006_bb0025","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1158\/1055-9965.EPI-14-0427","article-title":"Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers","volume":"23","author":"Chenoweth","year":"2014","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"1","key":"10.1016\/j.addbeh.2017.07.006_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14622200020032051","article-title":"Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings","volume":"3","author":"Cox","year":"2001","journal-title":"Nicotine & Tobacco Research"},{"issue":"1","key":"10.1016\/j.addbeh.2017.07.006_bb0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clpt.2004.02.011","article-title":"Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity","volume":"76","author":"Dempsey","year":"2004","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"4","key":"10.1016\/j.addbeh.2017.07.006_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2710.2006.00739.x","article-title":"Effect of delayed and\/or missed enteric-coated divalproex doses on valproic acid concentrations: Simulation and dose replacement recommendations for the clinician","volume":"31","author":"Dutta","year":"2006","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1016\/j.addbeh.2017.07.006_bb0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/PPA.S10620","article-title":"Varenicline for smoking cessation: Efficacy, safety, and treatment recommendations","volume":"4","author":"Ebbert","year":"2010","journal-title":"Patient Prefer Adherence"},{"issue":"12","key":"10.1016\/j.addbeh.2017.07.006_bb0050","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2165\/11537850-000000000-00000","article-title":"A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation","volume":"49","author":"Faessel","year":"2010","journal-title":"Clinical Pharmacokinetics"},{"issue":"6","key":"10.1016\/j.addbeh.2017.07.006_bb0055","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice","volume":"21","author":"Farmer","year":"1999","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1016\/j.addbeh.2017.07.006_bb0060","first-page":"Cd000011","article-title":"Interventions for enhancing medication adherence","author":"Haynes","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1016\/j.addbeh.2017.07.006_bb0065","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"British Journal of Addiction"},{"issue":"2","key":"10.1016\/j.addbeh.2017.07.006_bb0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0920-1211(90)90090-I","article-title":"Possible roles for frequent salivary antiepileptic drug monitoring in the management of epilepsy","volume":"6","author":"Herkes","year":"1990","journal-title":"Epilepsy Research"},{"issue":"2","key":"10.1016\/j.addbeh.2017.07.006_bb0075","first-page":"Cd009164","article-title":"Interventions to increase adherence to medications for tobacco dependence","author":"Hollands","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.addbeh.2017.07.006_bb0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Archives of General Psychiatry"},{"issue":"3\u20134","key":"10.1016\/j.addbeh.2017.07.006_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jchromb.2010.12.012","volume":"879","author":"Jacob","year":"2011","journal-title":"Journal of Chromatography B"},{"issue":"44","key":"10.1016\/j.addbeh.2017.07.006_bb0090","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.15585\/mmwr.mm6544a2","article-title":"Current cigarette smoking among adults\u2013United States, 2005\u20132015","volume":"65","author":"Jamal","year":"2016","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"4","key":"10.1016\/j.addbeh.2017.07.006_bb0095","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1037\/0022-006X.72.4.729","article-title":"Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers","volume":"72","author":"Killen","year":"2004","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.addbeh.2017.07.006_bb0100","doi-asserted-by":"crossref","first-page":"217047","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: An overview","volume":"2015","author":"Lam","year":"2015","journal-title":"BioMed Research International"},{"issue":"4","key":"10.1016\/j.addbeh.2017.07.006_bb0105","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.seizure.2007.02.006","article-title":"Clinical use of antiepileptic drugs at a referral centre for epilepsy","volume":"16","author":"Landmark","year":"2007","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.addbeh.2017.07.006_bb0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S2213-2600(14)70294-2","article-title":"Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: A randomised, double-blind placebo-controlled trial","volume":"3","author":"Lerman","year":"2015","journal-title":"The Lancet Respiratory Medicine"},{"issue":"2","key":"10.1016\/j.addbeh.2017.07.006_bb0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.18553\/jmcp.2013.19.2.125","article-title":"Adherence to varenicline and associated smoking cessation in a community-based patient setting","volume":"19","author":"Liberman","year":"2013","journal-title":"Journal of Managed Care Pharmacy"},{"issue":"9","key":"10.1016\/j.addbeh.2017.07.006_bb0120","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jocn.2005.12.037","article-title":"Monitoring salivary lamotrigine concentrations","volume":"13","author":"Malone","year":"2006","journal-title":"Journal of Clinical Neuroscience"},{"issue":"5","key":"10.1016\/j.addbeh.2017.07.006_bb0125","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11606-009-0926-8","article-title":"Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline","volume":"24","author":"McClure","year":"2009","journal-title":"Journal of General Internal Medicine"},{"issue":"22","key":"10.1016\/j.addbeh.2017.07.006_bb0130","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1001\/jama.288.22.2868","article-title":"Interventions to enhance patient adherence to medication prescriptions: Scientific review","volume":"288","author":"McDonald","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.addbeh.2017.07.006_bb0135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jsat.2015.05.002","article-title":"Concordance of direct and indirect measures of medication adherence in a treatment trial for cannabis dependence","volume":"57","author":"McRae-Clark","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"12","key":"10.1016\/j.addbeh.2017.07.006_bb0140","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1499-1654.2000.001616.x","article-title":"Adherence to treatment in children with epilepsy: Who follows \u201cdoctor's orders\u201d?","volume":"41","author":"Mitchell","year":"2000","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.addbeh.2017.07.006_bb0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biopsych.2008.08.028","article-title":"Varenicline improves mood and cognition during smoking abstinence","volume":"65","author":"Patterson","year":"2009","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.addbeh.2017.07.006_bb0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/clpt.1989.121","article-title":"Time to stop counting the tablets?","volume":"46","author":"Pullar","year":"1989","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"6","key":"10.1016\/j.addbeh.2017.07.006_bb0155","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/14622200701365335","article-title":"Bupropion and cognitive-behavioral therapy for smoking cessation in women","volume":"9","author":"Schmitz","year":"2007","journal-title":"Nicotine & Tobacco Research"},{"issue":"12","key":"10.1016\/j.addbeh.2017.07.006_bb0160","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00213-013-3421-1","article-title":"The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race","volume":"231","author":"Schnoll","year":"2014","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.addbeh.2017.07.006_bb0165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pbb.2008.10.016","article-title":"Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: A validation study","volume":"92","author":"Schnoll","year":"2009","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"8","key":"10.1016\/j.addbeh.2017.07.006_bb0170","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/ntr\/ntv068","article-title":"Correlates of adherence to Varenicline among HIV+ smokers","volume":"17","author":"Shelley","year":"2015","journal-title":"Nicotine & Tobacco Research"},{"issue":"5","key":"10.1016\/j.addbeh.2017.07.006_bb0175","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1360-0443.2007.01791.x","article-title":"Use of more nicotine lozenges leads to better success in quitting smoking","volume":"102","author":"Shiffman","year":"2007","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.addbeh.2017.07.006_bb0180","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1525-5050(03)00151-3","article-title":"Postictal serum levels of antiepileptic drugs for detection of noncompliance","volume":"4","author":"Specht","year":"2003","journal-title":"Epilepsy & Behavior"},{"issue":"7","key":"10.1016\/j.addbeh.2017.07.006_bb0185","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1158\/1055-9965.EPI-12-0236","article-title":"Reproducibility of the nicotine metabolite ratio in cigarette smokers","volume":"21","author":"St. Helen","year":"2012","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"2","key":"10.1016\/j.addbeh.2017.07.006_bb0190","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1360-0443.2003.00629.x","article-title":"Heterogeneity in 12-month outcome among female and male smokers","volume":"99","author":"Swan","year":"2004","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.addbeh.2017.07.006_bb0195","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1158\/1055-9965.EPI-14-1381","article-title":"Nicotine metabolite ratio (3-hydroxycotinine\/cotinine) in plasma and urine by different analytical methods and laboratories: Implications for clinical implementation","volume":"24","author":"Tanner","year":"2015","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"issue":"5","key":"10.1016\/j.addbeh.2017.07.006_bb0200","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","article-title":"Patient adherence to treatment: Three decades of research. A comprehensive review","volume":"26","author":"Vermeire","year":"2001","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"35","key":"10.1016\/j.addbeh.2017.07.006_bb0205","first-page":"1207","volume":"60","year":"2011","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"6","key":"10.1016\/j.addbeh.2017.07.006_bb0210","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","article-title":"Development and validation of brief measures of positive and negative affect: The PANAS scales","volume":"54","author":"Watson","year":"1988","journal-title":"Journal of Personality and Social Psychology"},{"issue":"1","key":"10.1016\/j.addbeh.2017.07.006_bb0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00007691-200102000-00004","article-title":"Relation between dosage of carbamazepine and concentration in hair and plasma samples from a compliant inpatient epileptic population","volume":"23","author":"Williams","year":"2001","journal-title":"Therapeutic Drug Monitoring"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460317302514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460317302514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T07:55:59Z","timestamp":1535615759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460317302514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":43,"alternative-id":["S0306460317302514"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2017.07.006","relation":{},"ISSN":["0306-4603"],"issn-type":[{"type":"print","value":"0306-4603"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measures and predictors of varenicline adherence in the treatment of nicotine dependence","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}